Insider · CIK 0001587697
Susan D. DeVore
Files at UNM (Unum Group), ELV (Elevance Health, Inc.), SOLV (Solventum Corp). First filing Mar 4, 2025, latest Aug 21, 2025.
Susan D. DeVore files SEC Form 4 as director at UNM (Unum Group), and also at ELV (Elevance Health, Inc.), SOLV (Solventum Corp). Since Mar 4, 2025, Susan D. DeVore has reported 1 open-market buy worth $375k and 1 open-market sell worth $809k, the latest filed on Aug 21, 2025.
A track record needs three past buys with six months of prices behind them; Susan D. DeVore has 0, so none is measured yet.
The newest scored trade: bought $375k of ELV on Aug 19, 2025, filed Aug 21, 2025, scored 48 (moderate).
Where the trades landed
Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.
ELV: Elevance Health, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
UNM: Unum Group
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 48Moderate | ELVbuy Elevance Health, Inc. | $375k 1,200 shares | +52% | +14% from low-43% from high | |
| 55Moderate | Unum Group | $809k 10,000 shares | -27% | +54% from low-1% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Mar 3, 2025 | UNM Unum Group | 10,000 0.01% of outstanding | $809k | Mar 3, 2025 | none |
Transactions
Every row this insider has filed, 15 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| May 26, 2026 | UNM Unum Group | AGrant or award Common Stock | +2,191 | $0.00 | $0 | 31,785 | May 28, 2026 |
| May 15, 2026 | SOLV Solventum Corp | AGrant or award Restricted Stock Unitsderivative | +3,300 | $0.00 | $0 | 3,300 | May 18, 2026 |
| May 13, 2026 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +563 | $0.00 | $0 | 4,065 | May 15, 2026 |
| Apr 30, 2026 | SOLV Solventum Corp | MOption exercise Common Stock | +3,403 | $0.00 | $0 | 8,947 | May 1, 2026 |
| Apr 30, 2026 | SOLV Solventum Corp | MOption exercise Restricted Stock Unitsderivative | -3,403 | $0.00 | $0 | 0 | May 1, 2026 |
| Mar 27, 2026 | SOLV Solventum Corp | MOption exercise Common Stock | +1,980 | $0.00 | $0 | 5,544 | Mar 30, 2026 |
| Mar 27, 2026 | SOLV Solventum Corp | MOption exercise Restricted Stock Unitsderivative | -1,980 | $0.00 | $0 | 0 | Mar 30, 2026 |
| Aug 19, 2025 | ELV Elevance Health, Inc. | POpen-market purchase Common Stock | +1,200 | $312.15 | $375k | 3,502 | Aug 21, 2025 |
| May 22, 2025 | UNM Unum Group | AGrant or award Common Stock | +2,198 | $0.00 | $0 | 29,594 | May 23, 2025 |
| May 14, 2025 | ELV Elevance Health, Inc. | AGrant or award Common Stock | +601 | $0.00 | $0 | 2,302 | May 16, 2025 |
| May 13, 2025 | SOLV Solventum Corp | MOption exercise Common Stock | +3,564 | $0.00 | $0 | 3,564 | May 15, 2025 |
| May 13, 2025 | SOLV Solventum Corp | MOption exercise Restricted Stock Unitsderivative | -3,564 | $0.00 | $0 | 0 | May 15, 2025 |
| Apr 30, 2025 | SOLV Solventum Corp | AGrant or award Restricted Stock Unitsderivative | +3,403 | $0.00 | $0 | 3,403 | May 2, 2025 |
| Mar 3, 2025 | UNM Unum Group | SOpen-market sale Common Stock | -5,577 | $80.62 | $450k | 31,819 | Mar 4, 2025 |
| Mar 3, 2025 | UNM Unum Group | SOpen-market sale Common Stock | -4,423 | $81.21 | $359k | 27,396 | Mar 4, 2025 |
Questions about Susan D. DeVore
Answered from the filings on this page, as of the latest one.
Is Susan D. DeVore buying or selling?
Not in the last 12 months. Susan D. DeVore's latest open-market trade on SEC Form 4 was bought $375k of ELV on Aug 19, 2025.
How did Susan D. DeVore's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Susan D. DeVore has 0.
Where does Susan D. DeVore file Form 4?
Susan D. DeVore has filed Form 4 at UNM (Unum Group); ELV (Elevance Health, Inc.); SOLV (Solventum Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.